Hoffman-Censits, J., Chu, X., Margulis, V., Shevrin, D., Cole, S., Raychaudhuri, R., Mittal, K., Psutka, S. P., Tripathi, A., Hahn, N. M., Carducci, M. A., Grivas, P. (2026). ECOG ACRIN EA8192 cohort C: A phase II trial of neoadjuvant gemcitabine/durvalumab in patients (pts) with high grade (HG) upper tract urothelial carcinoma (UTUC) ineligible for cisplatin-based chemotherapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.749